Pyoderma Gangrenosum with Neurofibromatosis: Understanding a Possible Relationship and Identifying Risk with Immunosuppressants

Authors

DOI:

https://doi.org/10.3126/njdvl.v21i2.56528

Keywords:

Azathioprine, Neurofibromatosis, Pyoderma Gangrenosum, Telogen effluvium

Abstract

Association of Pyoderma Gangrenosum with Neurofibromatosis is extremely rare; only one case has been reported so far. We present one such patient, who also developed bone marrow suppression after treatment with Azathioprine, and reported an acute onset of Telogen Effluvium. The rare association of these two seemingly unrelated conditions and the need to be vigilant about the possibility of myelosuppression with azathioprine presenting as sudden onset, severe alopecia is highlighted.

Downloads

Download data is not yet available.
Abstract
109
PDF
73

Author Biographies

Mihika Noronha, St. John’s Medical College, Bangalore, India

Former Resident, Department of Dermatology

Vijay Aithal, St John's Medical College, Bangalore, India

Professor and Head, Department of Dermatology

Downloads

Published

2023-10-02

How to Cite

Noronha, M., & Aithal, V. (2023). Pyoderma Gangrenosum with Neurofibromatosis: Understanding a Possible Relationship and Identifying Risk with Immunosuppressants. Nepal Journal of Dermatology, Venereology &Amp; Leprology, 21(2), 35–38. https://doi.org/10.3126/njdvl.v21i2.56528

Issue

Section

Case Reports